Nexalin Technology, Inc. (NXL)

USD 2.95

(-15.23%)

Market Cap (In USD)

37.94 Million

Revenue (In USD)

110.74 Thousand

Net Income (In USD)

-4.64 Million

Avg. Volume

469.99 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.253-4.49
PE
-
EPS
-
Beta Value
3.567
ISIN
US65345B2016
CUSIP
65345B201
CIK
1527352
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Mark White
Employee Count
-
Website
https://www.nexalin.com
Ipo Date
2022-09-16
Details
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.